HUP9900226A3 - Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin, process for producing them and pharmaceutical composition containing the same - Google Patents

Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin, process for producing them and pharmaceutical composition containing the same

Info

Publication number
HUP9900226A3
HUP9900226A3 HU9900226A HUP9900226A HUP9900226A3 HU P9900226 A3 HUP9900226 A3 HU P9900226A3 HU 9900226 A HU9900226 A HU 9900226A HU P9900226 A HUP9900226 A HU P9900226A HU P9900226 A3 HUP9900226 A3 HU P9900226A3
Authority
HU
Hungary
Prior art keywords
ala
trovafloxacin
polymorphs
prodrug
producing
Prior art date
Application number
HU9900226A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUP9900226A2 publication Critical patent/HUP9900226A2/hu
Publication of HUP9900226A3 publication Critical patent/HUP9900226A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
HU9900226A 1995-08-29 1996-07-05 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin, process for producing them and pharmaceutical composition containing the same HUP9900226A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US510995P 1995-08-29 1995-08-29

Publications (2)

Publication Number Publication Date
HUP9900226A2 HUP9900226A2 (hu) 1999-05-28
HUP9900226A3 true HUP9900226A3 (en) 1999-11-29

Family

ID=21714229

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900226A HUP9900226A3 (en) 1995-08-29 1996-07-05 Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin, process for producing them and pharmaceutical composition containing the same

Country Status (35)

Country Link
US (1) US6080756A (hu)
EP (1) EP0847400B1 (hu)
JP (1) JPH11509188A (hu)
KR (1) KR100274736B1 (hu)
CN (1) CN1193977A (hu)
AP (1) AP639A (hu)
AR (1) AR004507A1 (hu)
AT (1) ATE208790T1 (hu)
AU (1) AU696414B2 (hu)
BR (1) BR9610283A (hu)
CA (1) CA2230303C (hu)
CO (1) CO4480740A1 (hu)
CZ (1) CZ291524B6 (hu)
DE (1) DE69617027T2 (hu)
DK (1) DK0847400T3 (hu)
DZ (1) DZ2088A1 (hu)
ES (1) ES2164892T3 (hu)
GT (1) GT199600061A (hu)
HR (1) HRP960396A2 (hu)
HU (1) HUP9900226A3 (hu)
IL (1) IL122652A (hu)
MA (1) MA23965A1 (hu)
NO (1) NO309039B1 (hu)
NZ (1) NZ310542A (hu)
OA (1) OA10670A (hu)
PL (1) PL185709B1 (hu)
PT (1) PT847400E (hu)
RU (1) RU2151152C1 (hu)
SK (1) SK283354B6 (hu)
TN (1) TNSN96110A1 (hu)
TR (1) TR199800340T1 (hu)
UA (1) UA48982C2 (hu)
WO (1) WO1997008191A1 (hu)
YU (1) YU48296A (hu)
ZA (1) ZA967281B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) * 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
CN105510497A (zh) * 2015-11-30 2016-04-20 精晶药业股份有限公司 L-丙氨酰-l-丙氨酸的定量检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
IL122652A0 (en) 1996-08-16
GT199600061A (es) 1998-01-31
PT847400E (pt) 2002-03-28
JPH11509188A (ja) 1999-08-17
RU2151152C1 (ru) 2000-06-20
US6080756A (en) 2000-06-27
DE69617027T2 (de) 2002-03-21
WO1997008191A1 (en) 1997-03-06
ZA967281B (en) 1998-03-02
NO980863D0 (no) 1998-02-27
UA48982C2 (uk) 2002-09-16
AP639A (en) 1998-04-14
HUP9900226A2 (hu) 1999-05-28
PL185709B1 (pl) 2003-07-31
SK23798A3 (en) 1999-05-07
CA2230303C (en) 2001-07-24
PL325203A1 (en) 1998-07-06
SK283354B6 (sk) 2003-06-03
CA2230303A1 (en) 1997-03-06
HRP960396A2 (en) 1998-04-30
NO309039B1 (no) 2000-12-04
TR199800340T1 (xx) 1998-06-22
AP9600854A0 (en) 1996-10-31
NO980863L (no) 1998-02-27
CO4480740A1 (es) 1997-07-09
IL122652A (en) 2000-01-31
MA23965A1 (fr) 1997-04-01
AU696414B2 (en) 1998-09-10
BR9610283A (pt) 1999-03-16
KR100274736B1 (ko) 2000-12-15
ATE208790T1 (de) 2001-11-15
YU48296A (sh) 1998-12-23
NZ310542A (en) 1999-09-29
MX9801665A (es) 1998-08-30
ES2164892T3 (es) 2002-03-01
KR19990044231A (ko) 1999-06-25
DZ2088A1 (fr) 2002-07-22
CZ55298A3 (cs) 1999-02-17
EP0847400B1 (en) 2001-11-14
CN1193977A (zh) 1998-09-23
DK0847400T3 (da) 2002-03-25
EP0847400A1 (en) 1998-06-17
TNSN96110A1 (fr) 2005-03-15
AR004507A1 (es) 1998-12-16
DE69617027D1 (de) 2001-12-20
OA10670A (en) 2000-11-06
CZ291524B6 (cs) 2003-03-12
AU6135196A (en) 1997-03-19

Similar Documents

Publication Publication Date Title
HUP9802565A3 (en) N-benzyl-dioxothiazolidinylmethyl-benzamide derivatives, pharmaceutical compositions containing them and process for producing the same
HUP9602511A3 (en) Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these
HUP9600448A3 (en) Naphthyl compounds, pharmaceutical compositions containing them, process for producing them, their intermediates and their use
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9802323A3 (en) Pyrimidine derivatives , process for producing them and pharmaceutical compositions containing them
HUP9802839A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them and process for producing them
HUP9601529A3 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives, pharmaceutical compositions containing them, process for producing them and their use
HU9603484D0 (en) Pharmaceutical compositions and process for producing symptom-transduction
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
HUP9802694A3 (en) Benzamide derivatives, process for producing them and pharmaceutical compositions containing them
HUP9900055A3 (en) 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridin -derivatives, process for producing them and pharmaceutical compositions containing them
HUP9602489A3 (en) Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9700126A3 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives and pharmaceutical compositions containing them, process for producing the compounds and intermediates of them
HUP9603433A3 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9603023A3 (en) Substituted (sulfonimidamido)benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9602681A1 (en) Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9601034A2 (en) Aryl-alkyl-pyridazinone compounds, process for producing them, and pharmaceutical compositions containing them
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HU9600099D0 (en) Process for producing flavano-lignane compositions of improved release and absorption, compositions produced this way find use of them for producing pharmaceutical compositions
GB9505623D0 (en) Process for the preparation of gas-generating compositions
HU9602640D0 (en) Substituted benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9602748A2 (en) Novel n-pyrimidinyl-sulfonamides, process for producing them and pharmaceutical compositions containing them
HUP0003823A3 (en) Cyanoguanidines process for producing them and pharmaceutical compositions containing them